|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/55 | |
| A61K 9/22 | |||
| A61K 9/26 | |||
| A61K 9/16 | |||
| A61K 47/20 | |||
| A61K 47/14 | |||
| A61K 47/12 | |||
| A61K 9/48 | |||
| A61K 9/50 |
| (11) | Patento numeris | 2359830 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10015293.3 |
| Europos patento paraiškos padavimo data | 2007-04-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-08-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-09-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 794837 P | 2006-04-26 | US |
| (72) |
Bhatt, Padmanabh P., US
Kidane, Argaw, US
Edwards, Kevin, US
|
| (73) |
Supernus Pharmaceuticals, Inc.,
1550 East Gude Drive, Rockville, MD 20850,
US
|
| (54) | Controlled released preparations of oxcarbazepine having sigmoidal release profile |
| Controlled released preparations of oxcarbazepine having sigmoidal release profile |